133 related articles for article (PubMed ID: 2500525)
1. Subcutaneous versus intramuscular administration of Haemophilus influenzae type b vaccine.
Leung AK; Chiu AS; Siu TO
J R Soc Health; 1989 Apr; 109(2):71-3. PubMed ID: 2500525
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
[TBL] [Abstract][Full Text] [Related]
3. Haemophilus influenzae type b polysaccharide vaccine.
Cates KL
Pediatr Ann; 1986 Jun; 15(6):461-3, 467-8. PubMed ID: 3523406
[No Abstract] [Full Text] [Related]
4. Expert panel convened by FDA recommends Haemophilus influenzae type B vaccine should continue in use for children older than 2 years.
Marwick C
JAMA; 1987 Jun; 257(23):3182-3. PubMed ID: 3495673
[No Abstract] [Full Text] [Related]
5. World-wide strategies for immunization against invasive Haemophilus influenzae type b disease.
Iwarson S
Vaccine; 1993; 11 Suppl 1():S28-9. PubMed ID: 8447169
[TBL] [Abstract][Full Text] [Related]
6. FDA workshop on Haemophilus b polysaccharide vaccine--a preliminary report.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1987 Aug; 36(32):529-31. PubMed ID: 3112543
[No Abstract] [Full Text] [Related]
7. The introduction of Haemophilus influenzae B (Hib) vaccine.
Murphy JF
Ir Med J; 1992 Dec; 85(4):123. PubMed ID: 1473940
[No Abstract] [Full Text] [Related]
8. Efficacy of Haemophilus influenzae type b vaccines in Massachusetts children 18 to 59 months of age.
Loughlin AM; Marchant CD; Lett S; Shapiro ED
Pediatr Infect Dis J; 1992 May; 11(5):374-9. PubMed ID: 1630857
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Haemophilus influenzae type b disease.
Santosham M
Vaccine; 1993; 11 Suppl 1():S52-7. PubMed ID: 8447177
[TBL] [Abstract][Full Text] [Related]
10. National Advisory Committee on Immunization (NACI). Statement on Haemophilus influenzae type B conjugate vaccines for use in infants and children.
Can Commun Dis Rep; 1992 Dec; 18(23):169-76. PubMed ID: 1291012
[TBL] [Abstract][Full Text] [Related]
11. Haemophilus influenzae b polysaccharide revaccination: a continued role for the unconjugated vaccine.
Pichichero ME; Bracikowski A; Sullivan R; Madore D; Anderson P
Pediatr Infect Dis J; 1989 Jan; 8(1):20-3. PubMed ID: 2784202
[TBL] [Abstract][Full Text] [Related]
12. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines.
Mohle-Boetani JC; Ajello G; Breneman E; Deaver KA; Harvey C; Plikaytis BD; Farley MM; Stephens DS; Wenger JD
Pediatr Infect Dis J; 1993 Jul; 12(7):589-93. PubMed ID: 8346003
[TBL] [Abstract][Full Text] [Related]
13. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Apr; 34(15):201-5. PubMed ID: 3920487
[No Abstract] [Full Text] [Related]
14. Haemophilus influenzae type b prevention.
N Y State J Med; 1989 Jul; 89(7):430-1. PubMed ID: 2788257
[No Abstract] [Full Text] [Related]
15. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
[TBL] [Abstract][Full Text] [Related]
16. Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment.
Cochi SL; Broome CV; Hightower AW
JAMA; 1985 Jan; 253(4):521-9. PubMed ID: 3918181
[TBL] [Abstract][Full Text] [Related]
17. Protective efficacy of Haemophilus influenzae type b polysaccharide vaccine.
Shapiro ED; Berg AT
Pediatrics; 1990 Apr; 85(4 Pt 2):643-7. PubMed ID: 2179854
[TBL] [Abstract][Full Text] [Related]
18. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease.
Leung AK; Jadavji T
J R Soc Health; 1988 Oct; 108(5):180-1. PubMed ID: 3148720
[No Abstract] [Full Text] [Related]
19. Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group.
Black SB; Shinefield HR
Pediatr Infect Dis J; 1992 Aug; 11(8):610-3. PubMed ID: 1523069
[TBL] [Abstract][Full Text] [Related]
20. [When should vaccination against Haemophilus influenzae type b take place?].
Stickl HA
Med Monatsschr Pharm; 1991 Jan; 14(1):24. PubMed ID: 2017108
[No Abstract] [Full Text] [Related]
[Next] [New Search]
